NH SPAC 2 (206640) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.043x

Based on the latest financial reports, NH SPAC 2 (206640) has a cash flow conversion efficiency ratio of 0.043x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩10.46 Billion ≈ $7.09 Million USD) by net assets (₩244.18 Billion ≈ $165.48 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is NH SPAC 2 worth for the company's overall valuation and market capitalisation.

NH SPAC 2 - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how NH SPAC 2's cash flow conversion efficiency has evolved over time, based on yearly financial data.

NH SPAC 2 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of NH SPAC 2 ranked by their cash flow conversion efficiency. Explore NH SPAC 2 (206640) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Journey Medical Corp NASDAQ:DERM	-0.200x
Muhak Co. Ltd KO:033920	-0.009x
AirBoss of America Corp. TO:BOS	0.015x
Daios Plastics S.A. AT:DAIOS	N/A
Diamond Building Products Public Company Limited BK:DRT	0.054x
Atrem S.A. WAR:ATR	-0.108x
Tenaya Therapeutics Inc NASDAQ:TNYA	-0.188x
SR Bancorp, Inc. Common stock NASDAQ:SRBK	0.019x

Annual Cash Flow Conversion Efficiency for NH SPAC 2 (2015–2025)

The table below shows the annual cash flow conversion efficiency of NH SPAC 2 from 2015 to 2025. View NH SPAC 2 (206640) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩244.18 Billion ≈ $165.48 Million	₩22.08 Billion ≈ $14.96 Million	0.090x	-18.92%
2024-12-31	₩223.05 Billion ≈ $151.16 Million	₩24.88 Billion ≈ $16.86 Million	0.112x	-35.80%
2023-12-31	₩197.42 Billion ≈ $133.79 Million	₩34.30 Billion ≈ $23.24 Million	0.174x	+23.18%
2022-12-31	₩163.56 Billion ≈ $110.84 Million	₩23.07 Billion ≈ $15.63 Million	0.141x	-57.32%
2021-12-31	₩151.09 Billion ≈ $102.39 Million	₩49.93 Billion ≈ $33.83 Million	0.330x	-11.28%
2020-12-31	₩119.86 Billion ≈ $81.23 Million	₩44.64 Billion ≈ $30.25 Million	0.372x	+58.88%
2019-12-31	₩73.55 Billion ≈ $49.84 Million	₩17.24 Billion ≈ $11.68 Million	0.234x	+188.18%
2018-12-31	₩65.33 Billion ≈ $44.27 Million	₩5.31 Billion ≈ $3.60 Million	0.081x	+522.67%
2017-12-31	₩67.87 Billion ≈ $46.00 Million	₩886.74 Million ≈ $600.93K	0.013x	-91.67%
2016-12-31	₩75.17 Billion ≈ $50.94 Million	₩11.79 Billion ≈ $7.99 Million	0.157x	-3.10%
2015-12-31	₩59.50 Billion ≈ $40.32 Million	₩9.63 Billion ≈ $6.53 Million	0.162x	--

About NH SPAC 2

KQ:206640 Korea Medical Devices

Market Cap

$136.73 Million

₩201.76 Billion KRW

Market Cap Rank

#18099 Global

#789 in Korea

Share Price

₩9410.00

Change (1 day)

-0.63%

52-Week Range

₩9410.00 - ₩14710.00

All Time High

₩36222.75